Glial fibrillary acidic protein-apolipoprotein E (apoE) transgenic mice: Astrocyte-specific expression and differing biological effects of astrocyte- secreted apoE3 and apoE4 lipoproteins

Journal of Neuroscience

Volumn 18, Issue 9, 1998, Pages 3261-3272

  Sun, Yuling ^a   Wu, Shan ^a   Bu, Guojun ^b   Onifade, Moyosore K ^a   Patel, Shilen N ^a   LaDu, Mary Jo ^c   Fagan, Anne M ^a   Holtzman, David M ^a,b  

^a Ctr the Stud of Nerv Syst Inj   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF CHICAGO   (United States)

Author keywords

Alzheimer's disease; Apolipoprotein E; Astrocyte; Low density lipoprotein receptor related protein; Receptor associated protein; Transgenic

Indexed keywords

APOLIPOPROTEIN E; APOLIPOPROTEIN E3; APOLIPOPROTEIN E4; GLIAL FIBRILLARY ACIDIC PROTEIN; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN RECEPTOR;

ALZHEIMER DISEASE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; BRAIN INJURY; CONTROLLED STUDY; HIPPOCAMPUS; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; MOUSE; NERVE FIBER GROWTH; NEUROPIL; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TRANSGENIC MOUSE;

EID: 0032080231     PISSN: 02706474     EISSN: None     Source Type: Journal    
DOI: 10.1523/jneurosci.18-09-03261.1998     Document Type: Article

References (79)

1. Alberts MJ, Graffagnino C, McClenny C, DeLong D, Strittmatter W, Saunders AM, Roses AD (1995) ApoE genotype and survival from intracerebral hemorrhage. Lancet 346:575.
2. Barger SW, Mattson MP (1997) Isoform-specific modulation by apolipoprotein E of the activities of secreted β-amyloid precursor protein. J Neurochem 69:60-67.
3. Battey F, Gafvels ME, Fitzgerald DJ, Argraves WS, Chappell DA, Strauss JF, Strickland DK (1994) The 39 kDa receptor associated protein regulates ligand binding by the very low density lipoprotein receptor. J Biol Chem 269:23268-23273.
4. Bayles KR, Verina T, Dodel RC, Du Y, Altstiel L, Bender M, Hyslop P, Johnstone EM, Little SP, Cummins DJ, Piccardo P, Ghetti B, Paul SM (1997) Lack of apolipoprotein E dramatically reduces amyloid β-peptide deposition. Nat Genet 17:263-264.
5. Bellosta S, Nathan BP, Orth M, Dong LM, Mahley RW, Pitas RE (1995) Stable expression and secretion of aplipoproteins E3 and E4 in mouse neuroblastoma cells produces differential effects on neurite outgrowth. J Biol Chem 270:27063-27071.
6. Biere AL, Ostaszewski B, Stimson ER, Hyman BT, Maggio JE, Selkoe DJ (1996) Amyloid beta-peptide is transported on lipoproteins and albumin in human plasma. J Biol Chem 271:32916-32922.
7. Borghini I, Barja F, Pometta D, James RW (1995) Characterization of subpopulations of lipoprotein particles isolated from human cerebrospinal fluid. Biochim Biophys Acta 1255:192-200.
8. Bowman BH, Jansen L, Yang F, Adrian GS, Zhao M, Atherton SS, Buchanan JM, Greene R, Walter C, Herbert DC, Weaker FJ, Chiodo LK, Kagan-Hallet K, Hixson JE (1995) Discovery of a brain promoter from the human transferrin gene and its utilization for develop- ment of transgenic mice that express human apolipoprotein E alleles. Proc Natl Acad Sci USA 92:12115-12119.
9. Bowman BH, Yang F, Buchanan JM, Adrian GS, Martinez AO, Jansen L, Zhao M, Atherton SL, Hixson JE (1996) Human apoE protein localized in brains of transgenic mice. Neurosci Lett 219:57-59.
10. Boyles JK, Pitas RE, Wilson E, Mahley RW, Taylor JM (1985) Apolipoprotein E associated with astrocytic glia of the CNS and with nonmyelinating glia of the peripheral nervous system. J Clin Invest 76:1501-1513.
11. Brenner M, Kisseberth WC, Su Y, Besnard F, Messing A (1994) GFAP promoter directs astrocyte-specific expression in transgenic mice, J Neurosci 14:1030-1037.
12. Brown MD, Banker GA, Hussaini IM, Gonias SL, VandenBerg SR (1997) Low density lipoprotein receptor-related protein is expressed early and becomes restricted to a somatodendritic domain during neuronal differentiation in culture. Brain Res 747:313-317.
13. Bu G, Maksymovitch EA, Schwartz AL (1993) Receptor-mediated endocytosis of tissue-type plasminogen activator by low density lipoprotein receptor-related protein on human HepG2 cells. J Biol Chem 268:13002-13009.
14. Bu G, Maksymovitch EA, Nerborrae JM, Schwartz AL (1994) Expression and function of the low density lipoprotein receptor-related protein (LRP) in mammalian central neurons. J Biol Chem 269:18521-18528.
15. Chen Y, Lomnitski L, Michaelson DM, Shohami E (1997) Motor and cognitive deficits in apolipoprotein E-deficient mice after closed head injury. Neuroscience 80:1255-1262.
16. Christie RH, Chung H, Rebeck GW, Strickland D, Hyman BT (1996) Expression of the very low-density lipoprotein receptor (VLDL-r), an apolipoprotein-E receptor, in the CNS and in Alzheimer's disease. J Neuropathol Exp Neurol 55:491-498.
17. Evans KC, Berger EP, Cho C-G, Weisgraber KH, Lansbury PT (1994) Apolipoprotein E is a kinetic but not a thermodynamic inhibitor of amyloid formation: implications for the pathogenesis and treatment of Alzheimer's disease. Proc Natl Acad Sci USA 92:763-767.
18. Fagan AM, Gage FH (1994) Mechanisms of sprouting in the adult CNS: cellular responses in areas of terminal degeneration and reinnervation in the rat hippocampus. Neuroscience 58:705-725.
19. Fagan AM, Bu G, Sun Y, Daugherty A, Holtzman DM (1996a) Apolipoprotein E-containing high density lipoprotein promotes neurite outgrowth and is a ligand for the low density lipoprotein receptor-related protein. J Biol Chem 271:30121-30125.
20. Fagan AM, Suhr ST, Lucidi-Phillips CA, Peterson DA, Holtzman DM, Gage FH (1996b) Endogenous FGF-2 is important for cholinergic sprouting in the denervated hippocampus. J Neurosci 17:2499-2511.
21. Flood DG, Coleman PD (1986) Failed compensatory dendritic growth as a pathophysiological process in Alzheimer's disease. Can J Neurol Sci 13:475-479.
22. Goslin K, Banker G (1991) Rat hippocampal neurons in low-density culture. In: Culturing nerve cells (Banker G, Goslin K, eds), pp 251-281. Cambridge, MA: MIT.
23. Gutman CR, Strittmatter WJ, Weisgraber KH, Matthew WD (1997) Apolipoprotein E binds to and potentiates the biological activity of ciliary neurotrophic factor. J Neurosci 17:6114-6124.
24. Handelmann GE, Boyles JK, Weisgraber KH, Mahley RW, Pitas RE (1992) Effects of apolipoprotein E, β-very low density lipoproteins, and cholesterol on the extension of neurites by rabbit dorsal root ganglion neurons in vitro. J Lipid Res 33:1677-1688.
25. Herz J, Goldstein JL, Strickland DK, Ho YK, Brown MS (1991) 39 kDa protein modulates binding of ligands to low density lipoprotein receptor-related protein /α2-macroglobulin receptor. J Biol Chem 266:21232-21238.
26. Hogan B, Costantini F, Lacy E (1986) Manipulation of the mouse embryo. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory.
27. Holtzman DM, Bayney RM, Li Y, Khosrovi H, Berger CN, Epstein CJ, Mobley WC (1992) Dysregulation of gene expression in mouse trisomy 16, an animal model of Down syndrome. EMBO J 11:619-627.
28. Holtzman DM, Kilbridge J, Li Y, Cunningham ET, Lenn NJ, Clary DO, Reichardt LF, Mobley WC (1995a) TrkA expression in the CNS: evidence for the existence of several novel NGF-responsive CNS neurons. J Neurosci 15:1567-1576.
29. Holtzman DM, Pitas RE, Kilbridge J, Nathan B, Mahley RW, Bu G, Schwartz AL (1995b) LRP mediates apolipoprotein E-dependent neu- i rite outgrowth in a CNS-derived neuronal cell line. Proc Natl Acad Sci USA 92:9480-9484.
30. Kim DH, Iijima H, Goto K, Sakai J, Ishii H, Kim HJ, Suzuki H, Kondo H, Saeki S, Yamamoto T (1996) Human apolipoprotein E receptor 2. A novel lipoprotein receptor of the low density lipoprotein receptor family predominantly expressed in brain. J Biol Chem 271:8373-8380.
31. Koudinov AR, Koudinova NV, Kumar A, Beavis RC, Ghiso J (1996) Biochemical characterization of Alzheimer's soluble beta protein in human cerebrospinal fluid-association with high density lipoprotein. Biochem Biophys Res Commun 223:592-597.
32. Kowal RC, Herz J, Weisgraber KH, Mahley RW, Brown MS, Goldstein JL (1990) Opposing effects of apolipoproteins E and C on lipoprotein binding to low density lipoprotein receptor-related protein. J Biol Chem 265:10771-10779.
33. Krieger M, Herz J (1994) Structures and functions of multiligand lipoprotein receptors: macrophage scavenger receptors and LDL receptor-related protein (LRP). Annu Rev Biochem 63:601-637.
34. LaDu MJ, Falduto MT, Manelli AM, Reardon CA, Getz GS, Frail DE (1994) Isoform-specific binding of apolipoprotein E to β-amyloid. J Biol Chem 269:23404-23406.
35. LaDu MJ, Pederson TM, Frail DE, Reardon CA, Getz GS, Falduto MT (1995) Purification of apolipoprotein E attenuates isoform-specific binding to β-amyloid. J Biol Chem 270:9030-9042.
36. LaDu MJ, Gilligan SM, Lukens SR, Cabana VG, Reardon CA, Van Eldik LJ, Holtzman DM (1998) Nascent astrocyte particles differ from lipoproteins in CSF. J Neurochem, in press.
37. Laskowitz DT, Sheng H, Bart RD, Joyner KA, Roses AD, Warner DS (1997) Apolipoprotein E-deficient mice have increased susceptibility to focal cerebral ischemia. J Cereb Blood Flow Metab 17:753-758.
38. Linton MF, Gish R, Hubl ST, Butler E, Esquivel C, Bry WI, Boyles JK, Wardell MR, Young SG (1991) Phenotypes of apolipoprotein B and apolipoprotein E after liver transplantation. J Clin Invest 88:270-281.
39. Ma J, Yee A, Brewer HB, Das S, Potter H (1994) Amyloid-associated proteins alpha-1-antichymotrypsin and apolipoprotein E promote assembly of Alzheimer beta-protein into filaments. Nature 372:92-94.
40. Mahley RW (1988) Apolipoprotein E: cholesterol transport protein with expanding role in cell biology. Science 240:622-630.
41. Masliah E, Mallory M, Ge N, Alford M, Veinbergs I, Roses AD (1995) Neurodegeneration in the CNS of apoE-deficient mice. Exp Neurol 136:107-122.
42. MattsonMP (1994) Secreted forms of β-amyloid precursor protein modulate dendrite outgrowth and calcium responses to glutamate in cultured embryonic hippocampal neurons. J Neurobiol 25:439-450.
43. Miyata M, Smith JD (1996) Apolipoprotein E allele-spedfic antioxidant activity and effects on cytotoxicity by oxidative insults and beta-amyloid peptides. Nat Genet 14:55-61.
44. Mobley WC, Neve RL, Prusiner SB, McKinley MP (1988) Nerve growth factor increases mRNA levels for the prion protein and the betaamyloid protein precursor in developing hamster brain. Proc Natl Acad Sci USA 85:9811-9815.
45. Moestrup SK, Gliemann J, Pallesen G (1992) Distribution of the α2macroglobulin receptor/low density lipoprotein receptor-related protein in human tissues. Cell Tissue Res 269:375-382.
46. Mouchel Y, Lefrancois T, Pages C, Tardy M (1995) Apolipoprotein E expression in astrocytes: developmental pattern and regulation. NeuroReport 7:205-208.
47. Nakai M, Kawamata T, Maeda K, Tanaka C (1996) Expression of apoE mRNA in rat microglia. Neurosci Lett 211:41-44.
48. Narita M, Bu G, Holtzman DM, Schwartz AL (1997) The low density lipoprotein receptor-related protein (LRP), a multifunctional apoE receptor, modulates hippocampal neurite development. J Neurochem 68:587-595.
49. Naslund J, Thyberg J, Tjernberg LO, Wernstedt C, Karlstrom AR, Bogdanovic N, Gandy SE, Lannfelt L, Terenius L, Nordstedt C (1995) Characterization of stable complexes involving apolipoprotein E and the amyloid β peptide in Alzheimer's disease brain. Neuron 15:219-228.
50. Nathan BP, Bellosta S, Sanan DA, Weisgraber KH, Mahley RW. Pitas RE (1994) Differential effects of apolipoproteins E3 and E4 on neuronal growth in vitro. Science 264:850-852.
51. Nathan BP, Chang KC, Bellosta S, Brisch E, Ge N, Mahley RW. Pitas RE (1995) The inhibitory effect of apolipoprotein E4 on neurite outgrowth is associated with microtubule depolymerization. J Biol Chem 270:19791-19799.
52. Nicoll JAR, Roberts GW, Graham DI (1995) ApoE E4 allele is associated with deposition of amyloid beta-protein following head injury. Nat Med 1:135-137.
53. Piedrahita JA, Zhang SH, Hagaman JR, Oliver PM, Maeda N (1992) Generation of mice carrying a mutant apolipoprotein E gene inactivated by gene targeting in embryonic stem cells, Proc Natl Acad Sci USA 89:4471-4475.
54. Pitas RE, Boyles JK, Lee SH, Foss D, Mahley RW (1987a) Astrocytes synthesize apolipoprotein E and metabolize apolipoprotein E-containing lipoprotcins. Biochim Biophys Acta 917:148-161.
55. Pitas RE, Boyles JK, Lee SH, Hui D, Weisgraber KH (1987b) Lipoproteins and their receptors in the central nervous system. J Biol Chem 262:14352-14360.
56. Poirier J, Hess M, May PC, Finch CE (1991) Astrocytic apolipoprotein E mRNA and GFAP mRNA in hippocampus after entorhinal cortex lesioning. Mol Brain Res 11:97-106.
57. Poirier J, Baccichet A, Dea D, Gauthier S (1993) Cholesterol synthesis and lipoprotein reuptake during synaptic remodelling in hippocampus in adult rats. Neuroscience 55:81-90.
58. Rebeck GW, Reiter JS, Strickland DK, Hyman BT (1993) Apolipoprotein E in sporadic Alzheimer's disease: allelic variation and receptor interactions. Neuron 11:575-580.
59. Roheim PS, Carey M, Forte T, Vega GL (1979) Apolipoproteins in human cerebrospinal fluid. Proc Natl Acad Sci USA 76:4646-4649.
60. Rose K, Goldberg MP, Choi DW (1993) Cytotoxicity in murine neocortical cell culture. In vitro biological methods. In: Methods in toxicology (Tyson CA, Frazier JM, eds), pp 46-60. San Diego: Academic.
61. Roses AD (1997) Apolipoprotein E, a gene with complex biological interactions in the aging brain. Neurobiol Dis 4:170-186.
62. Sambrook J, Fritsch EF, Maniatis T (1989) Molecular cloning: a laboratory manual. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory.
63. Schmechel DE, Saunders AM, Strittmatter WJ, Grain BJ, Hulette CM, Joo SH, Pericak-Vance MA, Goldgaber D, Roses AD (1993) Increased amyloid β-peptide deposition in cerebral cortex as a consequence of apolipoprotein genotype in late-onset Alzheimer disease. Proc Natl Acad Sci USA 90:9649-9653.
64. Schwiegelshohn B, Presley JF, Gorecki M, Vogel T, Carpentier YA, Maxfield FR, Deckelbaum RJ (1995) Effects of apoprotein E on intracellular metabolism of model triglyceride-rich particles are distinct from effects on cell particle uptake. J Biol Chem 270:1761-1769.
65. SelkoeDJ (1994) Alzheimer's disease: a central role for amyloid. J Neuropathol Exp Neurol 53:438-447.
66. Slooter AJC, Tang MX, Vanduijn CM (1997) Apolipoprotein E epsilon-4 and the risk of dementia with stroke-a population based investigation. JAMA 277:818-821.
67. Stone DJ, Rozovsky I, Morgan TE, Anderson CP, Hajian H, Finch CE (1997) Astrocytes and microglia respond to estrogen with increased apoE mRNA in vivo and in vitro. Exp Neurol 143:313-318.
68. Strickland DK, Ashcom JD, Williams S, Battey F, Behre E, McTigue K, Battey JF, Argraves WS (1991) Primary structure of the α2macroglobulin receptor-associated protein. J Biol Chem 266: 13364-13369.
69. Strittmatter WJ, Roses AD (1996) Apolipoprotein E and Alzheimer's disease. Annu Rev Neurosci 19:53-77.
70. Strittmatter WJ, Saunders AM, Schmechel D, Pericak-Vance M, Enghild J, Salvesen GS, Roses AD (1993) Apolipoprotein E: high avidity binding to β-amyloid and increased frequency of type 4 allele in late-onset familial Alzhcimer disease. Proc Natl Acad Sci USA 90:1977-1981.
71. Strittmatter WJ, Saunders AM, Goedert M, Weisgraber KH, Dong L-M, Jakes R, Huang DY, Pericak-Vance M, Schmechel D, Roses AD (1994) Isoform-specifie interactions of apolipoprotein E with microtubule-associated tau: implications for Alzheimer disease. Proc Natl Acad Sci USA 91:11183-11186.
72. Sullivan PM, Mezdour H, Aratani Y. Knouff C, Najib J, Reddick RL, Quarfordt SH, Maeda N (1997) Targeted replacement of the mouse apolipoprotein E gene with the common human apoE3 allele enhances diet-induced hypercholesterolemia and atherosclerosis. J Biol Chem 272:17972-17980.
73. Tardiff BE, Newman MF, Saunders AM, Strittmatter WJ, Blumenthal JA, White MD,Croughwell ND, Davis Jr RD, Roses AD. Reves JG (1997) Preliminary report of a genetic basis for cognitive decline after cardiac operations. The neurologic outcome research group of the Duke Heart Center. Ann Thorac Surg 64:715-720.
74. Teasdale GM, Nicoll JAR. Murray G, Fiddes M (1997) Association of apolipoprotein E polymorphism with outcome after head injury. Lancet 350:1069-1071.
75. Weisgraber KH, Mahley RW (1996) Human apolipoprotein E: the Alzheimer's disease connection. FASEB J 10:1485-1494.
76. Wisniewski T, Frangione B (1992) Apolipoprotein E: a pathological chaperone protein in patients with cerebral and systemic amyloid. Neurosci Lett 135:235-238.
77. Wolf BB, Loppes MBS, VandenBerg SR, Gonias S (1992) Characterization and immunohistochemical localization of alpha 2-macroglobulin receptor (low density lipoprotein receptor-related protein) in human brain. Am J Pathol 141:37-42.
78. Xu P-T, Schmechel D, Rothrock-Christian T, Burkhart DS, Qiu H-L, Popko B, Sullivan P, Maeda N, Saunders AM, Roses AD, Gilbert JR (1996) Human apolipoprotein E2, E3, and E4 isoform-specific transgenic mice: human-like pattern of glial and neuronal immunoreactivity in CNS not observed in wild-type mice. Neurobiol Dis 3:229-245.
79. Zarepesi S, Kaye J, Camicioli R, Grimslid H, Oken B, Litt M, Nutt J, Bird T, Schellenberg G, Payami H (1997) Modulation of the age at onset of Parkinson's disease by apolipoprotein E genotype. Ann Neurol 42: 655-658.